A Prospective, Open-label Study To Assess The Pharmacokinetics, Safety & Efficacy Of Anidulafungin When Used To Treat Children With Invasive Candidiasis, Including Candidemia
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Anidulafungin (Primary) ; Fluconazole
- Indications Candidaemia; Candidiasis
- Focus Adverse reactions; Registrational
- Sponsors Pfizer
- 22 Feb 2018 Status changed from recruiting to completed.
- 15 Feb 2018 Planned End Date changed from 24 Apr 2018 to 28 Feb 2018.
- 15 Feb 2018 Planned primary completion date changed from 24 Apr 2018 to 28 Feb 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History